Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers
Methotrexate, a structural analogue of folic acid, is one of the most effective and extensively used drugs for treating many kinds of cancer or severe and resistant forms of autoimmune diseases. In this paper, we take an overview of the present state of knowledge with regards to complex mechanisms o...
Main Authors: | Przemysław Koźmiński, Paweł Krzysztof Halik, Raphael Chesori, Ewa Gniazdowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/10/3483 |
Similar Items
-
Common Shortcomings in Study on Radiopharmaceutical Design Research: A Case Study of <sup>99m</sup>Tc-Labelled Methotrexate
by: Przemysław Koźmiński, et al.
Published: (2021-09-01) -
New‐Onset Myasthenia Gravis Mimics Spinal Cord Injury After Zenker's Diverticulum Repair
by: Steffen E. Meiler, et al.
Published: (2023-04-01) -
Folic Acid/Methotrexate Functionalized Mesoporous Silica Nanoflakes from Different Supports: Comparative Study
by: Martyna Trukawka, et al.
Published: (2020-09-01) -
Disease Course in Hospitalized COVID-19 Patients with and without Rheumatic Disease and Its Relationship with Immunosuppressive Drug Use
by: Selime ERMURAT, et al.
Published: (2021-12-01) -
Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort
by: Wenxin Tian, et al.
Published: (2023-01-01)